ZA974919B - 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2- benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them. - Google Patents

3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2- benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ZA974919B
ZA974919B ZA9704919A ZA974919A ZA974919B ZA 974919 B ZA974919 B ZA 974919B ZA 9704919 A ZA9704919 A ZA 9704919A ZA 974919 A ZA974919 A ZA 974919A ZA 974919 B ZA974919 B ZA 974919B
Authority
ZA
South Africa
Prior art keywords
benzisoxazole
piperid
piperazin
processes
preparation
Prior art date
Application number
ZA9704919A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Mark Millan
Mauricette Brocco
Valerie Audinot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA974919B publication Critical patent/ZA974919B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA9704919A 1996-06-04 1997-06-04 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2- benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them. ZA974919B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9606866A FR2749304B1 (fr) 1996-06-04 1996-06-04 Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA974919B true ZA974919B (en) 1997-12-30

Family

ID=9492694

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704919A ZA974919B (en) 1996-06-04 1997-06-04 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2- benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them.

Country Status (19)

Country Link
US (1) US5780474A (pl)
EP (1) EP0811622B1 (pl)
JP (1) JPH1059967A (pl)
CN (1) CN1073565C (pl)
AT (1) ATE192745T1 (pl)
AU (1) AU715266B2 (pl)
BR (1) BR9703447A (pl)
CA (1) CA2207835C (pl)
DE (1) DE69701923T2 (pl)
DK (1) DK0811622T3 (pl)
ES (1) ES2148916T3 (pl)
FR (1) FR2749304B1 (pl)
GR (1) GR3033996T3 (pl)
HU (1) HUP9700992A3 (pl)
NO (1) NO308360B1 (pl)
NZ (1) NZ314992A (pl)
PL (1) PL187005B1 (pl)
PT (1) PT811622E (pl)
ZA (1) ZA974919B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7168084B1 (en) 1992-12-09 2007-01-23 Sedna Patent Services, Llc Method and apparatus for targeting virtual objects
US9286294B2 (en) 1992-12-09 2016-03-15 Comcast Ip Holdings I, Llc Video and digital multimedia aggregator content suggestion engine
US6263443B1 (en) * 1997-10-11 2001-07-17 Agere Systems Guardian Corp. Simplified data link protocol processor
ATE367389T1 (de) * 1998-02-09 2007-08-15 Duphar Int Res Benzisoxazolderivate mit d4-antagonistischer wirkung
US9924234B2 (en) 1998-07-23 2018-03-20 Comcast Ip Holdings I, Llc Data structure and methods for providing an interactive program
US6754905B2 (en) 1998-07-23 2004-06-22 Diva Systems Corporation Data structure and methods for providing an interactive program guide
EP1097587A1 (en) * 1998-07-23 2001-05-09 Diva Systems Corporation Interactive user interface
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US7096487B1 (en) 1999-10-27 2006-08-22 Sedna Patent Services, Llc Apparatus and method for combining realtime and non-realtime encoded content
US6904610B1 (en) 1999-04-15 2005-06-07 Sedna Patent Services, Llc Server-centric customized interactive program guide in an interactive television environment
US6754271B1 (en) 1999-04-15 2004-06-22 Diva Systems Corporation Temporal slice persistence method and apparatus for delivery of interactive program guide
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
HUP0202706A3 (en) * 1999-09-14 2004-12-28 Aventis Pharmaceuticals Inc Br Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
AU1576801A (en) 1999-10-27 2001-05-08 Diva Systems Corporation Picture-in-picture and multiple video streams using slice-based encoding
FR2803298A1 (fr) * 1999-12-30 2001-07-06 Adir Nouvelles urees lineaires ou cycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2001292276A1 (en) * 2000-09-27 2002-04-08 Toray Industries, Inc. Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
US7793326B2 (en) 2001-08-03 2010-09-07 Comcast Ip Holdings I, Llc Video and digital multimedia aggregator
US7908628B2 (en) 2001-08-03 2011-03-15 Comcast Ip Holdings I, Llc Video and digital multimedia aggregator content coding and formatting
WO2005053796A1 (en) * 2003-12-02 2005-06-16 B & B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
EP1547650A1 (en) * 2003-12-02 2005-06-29 B & B Beheer NV Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US20050119249A1 (en) * 2003-12-02 2005-06-02 Erik Buntinx Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2006090224A1 (en) * 2005-02-25 2006-08-31 Pfizer Japan Inc. Benzisoxazole derivatives
EP2344482B1 (en) * 2008-09-23 2012-08-15 F. Hoffmann-La Roche AG Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
EP2337783A1 (en) * 2008-09-23 2011-06-29 F. Hoffmann-La Roche AG Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors
US9154813B2 (en) 2011-06-09 2015-10-06 Comcast Cable Communications, Llc Multiple video content in a composite video stream
CN116354925B (zh) * 2021-12-27 2025-09-09 江苏恩华药业股份有限公司 吡唑衍生物及其应用
CN116354924B (zh) * 2021-12-27 2025-05-30 江苏恩华药业股份有限公司 一种2-咪唑酮衍生物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754641A (fr) * 1969-08-11 1971-02-10 Geigy Ag J R Derives de l'imidazolidinone et medicaments contenant de tels derives
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
EP0635506A4 (en) * 1993-02-04 1995-04-12 Meiji Seika Co CONNECTION WITH ANTIPSYCHOTIC EFFECT.

Also Published As

Publication number Publication date
ATE192745T1 (de) 2000-05-15
NO972510D0 (no) 1997-06-02
HUP9700992A3 (en) 1999-03-29
HUP9700992A2 (hu) 1998-12-28
AU2464997A (en) 1997-12-11
AU715266B2 (en) 2000-01-20
DE69701923D1 (de) 2000-06-15
NO308360B1 (no) 2000-09-04
EP0811622B1 (fr) 2000-05-10
DK0811622T3 (da) 2000-09-11
CA2207835C (fr) 2001-10-02
PT811622E (pt) 2000-08-31
FR2749304B1 (fr) 1998-06-26
NO972510L (no) 1997-12-05
CA2207835A1 (fr) 1997-12-04
PL187005B1 (pl) 2004-04-30
US5780474A (en) 1998-07-14
JPH1059967A (ja) 1998-03-03
CN1171401A (zh) 1998-01-28
ES2148916T3 (es) 2000-10-16
HU9700992D0 (en) 1997-07-28
EP0811622A1 (fr) 1997-12-10
NZ314992A (en) 1999-05-28
DE69701923T2 (de) 2000-12-14
FR2749304A1 (fr) 1997-12-05
PL320325A1 (en) 1997-12-08
CN1073565C (zh) 2001-10-24
GR3033996T3 (en) 2000-11-30
BR9703447A (pt) 1998-11-10

Similar Documents

Publication Publication Date Title
HU9700992D0 (en) New 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them
TW226991B (pl)
NO962210D0 (no) Nye piperazin, piperidin og tetrahydropyridinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
AU2888892A (en) 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine
AU6798190A (en) Serotonin antagonists, their preparation and compositions containing them
ATE121621T1 (de) Verwendung von tetrahydrothienopyridinderivate als angiogenese-inhibitoren.
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
GR871231B (en) Preparation method of novel dihydro -1,4 pyridine derivatives
ZA987963B (en) Disubstituted trans-3,4,4a,5,6,10b-haxahydro-2H-naphth(1,2-b)-1,4-oxazines a process for their preparation and pharmaceutical compositions containing them
DK0916671T3 (da) Metalloprotease-inhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætniger indeholdende sådanne inhibitorer
DE3470537D1 (en) Quinoline derivatives
IL116386A (en) Preparation of pharmaceutical compositions containing 1,2-bridged 1,4-dihydropyridines for the control of cns disorders and sickle cell anemia certain such novel compounds and their preparation
ES2098517T3 (es) Derivados de 1,2,4-tiadiazino(3,4-b)benzotiazol, su preparacion y los medicamentos que los contienen.
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments